טוען...
Selective LXR agonist DMHCA corrects retinal and bone marrow dysfunction in type 2 diabetes
In diabetic dyslipidemia, cholesterol accumulates in the plasma membrane, decreasing fluidity and thereby suppressing the ability of cells to transduce ligand-activated signaling pathways. Liver X receptors (LXRs) make up the main cellular mechanism by which intracellular cholesterol is regulated an...
שמור ב:
| הוצא לאור ב: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Clinical Investigation
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7406260/ https://ncbi.nlm.nih.gov/pubmed/32641586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.137230 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|